Список литературы
1. Kolm I, Hofbauer G, Braun RP. Hautkrebsvorsorge [Early diagnosis of skin cancer]. Ther Umsch. 2010;67(9):439-46. German. doi: 10.1024/0040-5930/a000077
2. Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma. Mod Pathol. 2021 Mar;34(3):572-583. doi: 10.1038/s41379-020-0641-x
3. Basurto-Lozada P, Molina-Aguilar C, Castaneda-Garcia C, et al. Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease. Pigment Cell Melanoma Res. 2021;34(1):59-71. doi:10.1111/pcmr.12885
4. Hogue L., Harvey V.M. Basal Cell Carcinoma, Squamous Cell Carcinoma, and Cutaneous Melanoma in Skin of Color Patients. Dermatol.Clin. 2019;37(4):519-526.
5. Ozdemir F, Errico MA, Yaman B, Karaarslan I. Acral lentiginous melanoma in the Turkish population and a new dermoscopic clue for the diagnosis. Dermatol Pract Concept. 2018;8(2):140-148. doi:10.5826/dpc.0802a14
6. Elefanti L, Zamuner C, Del Fiore P, Stagni C, Pellegrini S, Dall'Olmo L, Fabozzi A, Senetta R, Ribero S, Salmaso R, Mocellin S, Bassetto F, Cavallin F, Tosi AL, Galuppini F, Dei Tos AP, Menin C, Cappellesso R. The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI). Int J Mol Sci. 2021 Apr 7;22(8):3826. doi:10.3390/ijms22083826
7. Goydos JS, Shoen SL. Acral Lentiginous Melanoma. Cancer Treat Res. 2016;167:321-9. doi: 10.1007/978-3-319-22539-5_14
8. Saida T, Miyazaki A, Oguchi S, Ishihara Y, Yamazaki Y, Murase S, et al. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan. Arch Dermatol 2004; 140: 1233-1238. doi: 10.1001 / archderm.140.10.1233Fortin P.T.,
9. Freiberg A.A., Rees R., Sondak V.K., Johnson T.M. Malignant melanoma of the foot and ankle. J. Bone Jt. Surg. 1995;77:1396–1403. doi: 10.2106/00004623-199509000-00016
10. Howard MD, Xie C, Wee E, Wolfe R, McLean CA, Kelly JW, Pan Y. Acral lentiginous melanoma: differences in survival compared with other subtypes. Br J Dermatol. 2020 Apr;182(4):1056-1057. doi: 10.1111/bjd.18620.
11. Saida T, Koga H, Uhara H. Key points in dermoscopic differentiation between early acral melanoma and acral nevus. J Dermatol. 2011;38(1):25-34. doi: 10.1111/j.1346-8138.2010.01174.x.
12. Byrd KMWilson DCHoyler SSPeck GL Advanced presentation of melanoma in African Americans. J Am Acad Dermatol 2004;50 (1) 21- 24
13. Phan A, Dalle S, Touzet S, Ronger-Savlé S, Balme B, Thomas L. Dermoscopic features of acral lentiginous melanoma in a large series of 110 cases in a white population. Br J Dermatol. 2010 Apr;162(4):765-71. doi: 10.1111/j.1365-2133.2009.09594.x. Epub 2009 Nov 18. PMID: 19922528.
14. Desai A, Ugorji R, Khachemoune A. Acral melanoma foot lesions. Part 1: epidemiology, aetiology, and molecular pathology. Clin Exp Dermatol. 2017 Dec;42(8):845-848. doi: 10.1111/ced.13243
15. Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145(4):427-434. doi:10.1001/archdermatol.2008.609
16. Arrington JH, Reed RJ, Ichinose H, Krementz ET. Plantar lentiginous melanoma: A distinctive variant of human cutaneous malignant melanoma. Am Journal of Surgical Pathology. 1977;1(2):131–143.
17. Durbec F., Martin L., Derancourt C., Grange F. Melanoma of the hand and foot: Epidemiological, prognostic and genetic features. A systematic review. Br. J. Dermatol. 2012;166:727–739. doi: 10.1111/j.1365-2133.2011.10772.x 9-12
18. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET; Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007 Mar;82(3):364-80. doi: 10.4065/82.3.364
19. Cabrera, M., Silva, V., Díaz de Medina, DJ, Hoell, B., Guglielmetti, V., Rohmann, K. et al. (1994). Estudio clinico de 113 casos demelanoma maligno . Revista Medica de Chile , 122 ( 8 ), 900–906.
20. Feibleman CE, Stoll H, Maize JC. Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer. 1980 Dec1;46(11):2492-504. doi:10.1002/1097-0142(19801201)46:11<2492::aid cncr2820461130>3.0.co;2-j
21. Minagawa A, Omodaka T, Okuyama R. Melanomas and Mechanical Stress Points on the Plantar Surface of the Foot. N Engl J Med. 2016 Jun 16;374(24):2404-6
22. Sheen, Y.‐S. , Liao, Y.‐H. , Lin, M.‐H. , Chen, J.‐S. , Liau, J.‐Y. , Tseng, Y.‐J., et al. A clinicopathological analysis of 153 acralmelanomas and the relevance of mechanical stress. Scientific Reports, 2017; 7(1), 5564.
23. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41:45–60
24. Usher-Smith JA, Emery J, Kassianos AP, Walter FM. Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014;23:1450–63.
25. Gruber SB, Armstrong BK. Cutaneous and ocular melanoma. In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2006. pp. 1196–1229.
26. Garibyan L,Fisher DE.How sunlight causes melanoma.Curr Oncol Rep.2010 Sep;12(5):319-26. doi: 10.1007/s11912-010-0119-y.
27. Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. Arch Pathol Lab Med. 2020 Apr;144(4):500-522. doi: 10.5858/arpa.2019-0561-RA.
28. Fallah, M. , Pukkala, E. , Sundquist, K. , Tretli, S. , Olsen, J. H. , Tryggvadottir, L. , & Hemminki, K. (2014). Familial melanoma by histology and age: Joint data from five Nordic countries. European Journal of Cancer, 2014; 50(6), 1176–1183.10.1016/j.ejca.2013.12.023
29. Liu XK, Li J. Acral lentiginous melanoma. Lancet.2018 Jun 9;391(10137):e21. doi: 10.1016/S0140-6736(18)31071-7.]. Bello DM,Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013 Oct;20(11):3618-25. doi: 10.1245/s10434-013-3089-0
30. Bradford P.T. Skin Cancer in Skin of Color. Dermatol Nurs. 2009:21(4): 170–178].
31. Ward-Peterson M, Acuna JM, Alkhalifah MK, Nasiri AM, Al-Akeel ES, Alkhaldi TM, et al. Association between race/ethnicity and survival of melanoma patients in the United States over 3 decades: A secondary analysis of SEER data. Medicine. 2016;95(17):e3315.
32. Culp MB, Lunsford NB. Melanoma Among Non-Hispanic Black Americans. Prev Chronic Dis 2019;16:180640.
33. Oh TS, Bae EJ, Ro KW, Seo SH, Son SW, Kim IH. Acral Lentiginous Melanoma Developing during Long-standing Atypical Melanosis: Usefulness of Dermoscopy for Detection of Early Acral Melanoma. Ann Dermatol. 2011;23(3):400-404. doi:10.5021/ad.2011.23.3.400
34. Park HS, Cho KH. Acral lentiginous melanoma in situ: a diagnostic and management challenge. Cancers (Basel). 2010;2(2):642-652. doi:10.3390/cancers2020642.
35. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902-8. doi: 10.1097/00000658-197011000-00017.12885
36. Seyed Jafari SM, Lieberherr S, Cazzaniga S, Beltraminelli H, Haneke E, Hunger RE. Melanoma of the Nail Apparatus: An Analysis of Patients' Survival and Associated Factors. Dermatology. 2022;238(1):156-160. doi: 10.1159/000514493.
37. Liopyris K., Navarrete-Dechent C., Mancebo S.E. et al. Dermoscopic appearance of amelanotic volar melanoma compared with volar angioma. JAMA Dermatol. 2019;155(4):500-501. doi:10.1001/jamadermatol.2018.5487
38. Chang JW. Acral Melanoma: A Unique Disease in Asia. JAMA Dermatol. 2013;149(11):1272–1273. doi:10.1001/jamadermatol.2013.5941
39. Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013 Oct;20(11):3618-25. doi: 10.1245/s10434-013-3089-0.
40. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008 Jan 1;26(1):66-75. doi:10.1200/JCO.2007.12.3604.
41. Hall KH, Rapini RP. Acral Lentiginous Melanoma. 2021 Jul 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32644539.
42. Rigby HS, Briggs JC. Subungual melanoma: a clinico-pathological study of 24 cases. Br J Plast Surg. 1992 May-Jun;45(4):275-8. doi: 10.1016/0007-1226(92)90051-x
43. Mikhail GR. Hutchinson's sign. J Dermatol Surg Oncol. 1986 May;12(5):519-21. doi: 10.1111/j.1524 4725.1986.tb01943.x
44. DeMartinis NC, Cohen PR. Non-Melanoma-Associated Dyschromia of the Proximal Nail Fold. Cureus. 2016;9;8(12):e922. doi:10.7759/cureus.922.
45. Kawabata Y, Ohara K, Hino H, Tamaki K. Two kinds of Hutchinson's sign, benign and malignant. J Am Acad Dermatol. 2001 Feb;44(2):305-7. doi: 10.1067/mjd.2001.112398
46. Dika E, Patrizi A, Fanti PA, Chessa MA, Reggiani C, Barisani A, Piraccini BM. The Prognosis of Nail Apparatus Melanoma: 20 Years of Experience from a Single Institute. Dermatology. 2016;232(2):177-84. doi: 10.1159/000441293
47. Blessing K., Kernohan N.M., Park K.G.M. Subungual malignant melanoma: Clinicopathological features of 100 cases. Histopathology. 1991;19:425–430. doi: 10.1111/j.1365-2559.1991.tb00232.x.
48. Geizhals S, Lipner SR. Retrospective Case Series on Risk Factors, Diagnosis and Treatment of Pseudomonas aeruginosa Nail In fections. Am J Clin Dermatol. 2020 Apr;21(2):297-302. doi: 10.1007/s40257-019-00476-0.
49. Lee H, Mun JH, Cho S, Park H. Clinical analysis of Pseudomonas aeruginosa-positive and -negative green nail syndrome cases:A single center retrospective analysis. J Dermatol. 2021 Jul;48(7):1073-1076. doi: 10.1111/1346-8138.15832.
50. Glaser DA, Remlinger K. Blue nails and acquired immunodeficiency syndrome: not always associated with azidothymidine use.Cutis. 1996 ;57(4):243-4.
51. Vignes S, Baran R. Yellow nail syndrome:a review. Orphanet J Rare Dis. 2017 Feb 27;12(1):42. doi:10.1186/s13023-017-0594-4.
52. Tokonami A, Ohta R, Tanaka Y, Amano S, Sano C. Pericarditis With Cardiac Tamponade Mimicking Yellow Nail Syndrome in a Patient With Rheumatoid Arthritis and a Paucity of Joint Symptoms. Cureus. 2022 Jan 23;14(1):e21523. doi: 10.7759/cureus.21523.
53. Fukaya T, Kasai H, Saito M, Sasatani Y, Urushibara T, Sakao S. Yellow nail syndrome with massive chylothorax after esophagectomy: A case report. Respir Med Case Rep. 2021 Jun 12;33:101448. doi: 10.1016/j.rmcr.2021.101448.
54. Akcam M, Artan R, Akcam FZ, Yilmaz A. Nail discoloration induced by doxycycline. Pediatr Infect Dis J. 2005 Sep;24(9):845-6. doi: 10.1097/01.inf.0000177283.71692.56
55. Oppel T, Korting HC. Onychodystrophy and its management. Ger Med Sci. 2003;1:Doc02.
56. Kaur R, Kashyap B, Bhalla P. Onychomycosis--epidemiology, diagnosis and management. Indian J Med Microbiol. 2008 Apr-Jun;26(2):108-16
57. Jefferson J, Rich P. Melanonychia. Dermatol Res Pract. 2012;2012:952186. doi: 10.1155/2012/952186.
58. Skowron F, Combemale P, Faisant M, Baran R, Kanitakis J, Dupin M. Functional melanonychia due to involvement of the nail matrix in systemic lupus erythematosus. J Am Acad Dermatol. 2002 Aug;47(2 Suppl):S187-8. doi: 10.1067/mjd.2002.108494.
59. Koch K, Tikly M. Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus. Lupus. 2019 Jul;28(8):1021-1026. doi: 10.1177/0961203319856091
60. Singal A, Bisherwal K. Melanonychia: Etiology, Diagnosis, and Treatment. Indian Dermatol Online J. 2020;11(1):1-11. Published 2020 Jan 13. doi:10.4103/idoj.IDOJ_167_19
61. Richert B, Iorizzo M, Tosti A, André J. Nail bed lichen planus associated with onychopapilloma. 2007; 156(5) 5:1071-1072.
62. Kumar S, Dixit R, Karmakar S, Paul S. Unusual nail pigmentation following cyclophosphamide-containing chemotherapy regimen. Indian J Pharmacol. 2010 Aug;42(4):243-4. doi: 10.4103/0253-7613.68433
63. Daniel CR, Scher RK. Nail changes caused by systemic drugs or ingestants. Dermatol Clin. 1985 Jul;3(3):491-500.
64. André J, Lateur N. Pigmented nail disorders. Dermatol Clin. 2006;24(3):329-39.
65. Baran R, Kechijian P. Longitudinal melanonychia (melanonychia striata): diagnosis and management. J Am Acad Dermatol. 1989 Dec;21(6):1165-75. doi: 10.1016/s0190-9622(89)70324-8
66. Fernandez‐Flores, A. , & Cassarino, D. S. Histopathological diagnosis of acral lentiginous melanoma in early stages. Annals of Diagnostic Pathology, 2017; 26, 64–69. 10.1016/j.anndiagpath.2016.08.005
67. Goettmann-Bonvallot S, André J, Belaich S. Longitudinal melanonychia in children: a clinical and histopathologic study of 40 cases. J Am Acad Dermatol. 1999 Jul;41(1):17-22. doi: 10.1016/s0190-9622(99)70399-3.
68. Yim SH, Kwon IS, Hong D, Jung KE, Lee Y, Seo YJ, Choi CW. Predictor of Subungual Melanoma against Benign Longitudinal Melanonychia: A Retrospective Cohort Study from Korea. Ann Dermatol. 2021 Apr;33(2):147-153. doi: 10.5021/ad.2021.33.2.147.
69. Ko D, Oromendia C, Scher R, Lipner SR. Retrospective single-center study evaluating clinical and dermoscopic features of lon gitudinal melanonychia, ABCDEF criteria, and risk of malignancy. J Am Acad Dermatol. 2019 May;80(5):1272-1283. doi:10.1016/j.jaad.2018.08.033.
70. Levit EK, Kagen MH, Scher RK, Grossman M, Altman E. The ABC rule for clinical detection of subungual melanoma. J Am AcadDermatol. 2000 Feb;42(2 Pt 1):269-74. doi: 10.1016/S0190-9622(00)90137-3.
71. Sawada M, Yokota K, Matsumoto T, Shibata S, Yasue S, Sakakibara A, Kono M, Akiyama M. Proposed classification of longitudinal melanonychia based on clinical and dermoscopic criteria. Int J Dermatol. 2014 May;53(5):581-5. doi: 10.1111/ijd.12001
72. Ezenwa E, Stein JA, Krueger L. Dermoscopic features of neoplasms in skin of color: A review. Int J Womens Dermatol. 2021;7(2):145-151. Published 2021 Jan 19. doi:10.1016/j.ijwd.2020.11.009
73. Braun RP, Thomas L, Dusza SW, Gaide O, Menzies S, Dalle S, Blum A, Argenziano G, Zalaudek I, Kopf A, Rabinovitz H, Oliviero M, Perrinaud A, Cabo H, Pizzichetta M, Pozo L, Langford D, Tanaka M, Saida T, Perusquia Ortiz AM, Kreusch J, De Giorgi V, Piccolo D, Grichnik JM, Kittler H, Puig S, Malvehy J, Seidenari S, Stanganelli I, French L, Marghoob AA. Dermoscopy of acral melanoma: a multicenter study on behalf of the international dermoscopy society. Dermatology. 2013;227(4):373-80. doi:10.1159/000356178.
74. Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol. 1987;17:571–583. doi: 10.1016/S0190-9622(87)70239-4
75. Kittler H. Evolution of the Clinical, Dermoscopic and Pathologic Diagnosis of Melanoma. Dermatol Pract Concept. 2021 Jul 1;11(Suppl 1):e2021163S. doi: 10.5826/dpc.11S1a163S
76. Lallas, A. , Kyrgidis, A. , Koga, H. , Moscarella, E. , Tschandl, P. , Apalla, Z. , … Argenziano, G. (2015). The BRAAFF checklist: A new dermoscopic algorithm for diagnosing acral melanoma. British Journal of Dermatology, 173(4), 1041–1049.
77. Saida T, Koga H. Dermoscopic patterns of acral melanocytic nevi: their variations, changes, and significance. Arch Dermatol. 2007 Nov;143(11):1423-6. doi: 10.1001/archderm.143.11.1423.
78. Wawrzynkiewicz M, Pastuszczak M, Chlebicki M, Wojas-Pelc A. Acral melanocytic nevi in the Polish population: prevalence, clinical characteristics and dermoscopic patterns. Postepy Dermatol Alergol. 2019 Oct;36(5):581-588. doi: 10.5114/ada.2018.77500.
79. Han B, Hur K, Ohn J, Lim SS, Mun JH. Acral lentiginous melanoma in situ: dermoscopic features and management strategy. SciRep. 2020 Nov 25;10(1):20503. doi: 10.1038/s41598-020-77425-z.
80. Darmawan CC, Jo G, Montenegro SE, Kwak Y, Cheol L, Cho KH, Mun JH. J Am Acad Dermatol. Early detection of acral melanoma: A review of clinical, dermoscopic, histopathologic, and molecular characteristics.2019; 81(3):805-812.
81. Roh D, Shin K, Kim WI, Yang MY, Lee WK, Kim HS, Ko HC, Kim BS, Kim MB. Comparison of dermoscopic features between congenital and acquired acral melanocytic nevi in Korean patients. J Eur Acad Dermatol Venereol. 2020 May;34(5):1004-1009. doi: 10.1111/jdv.16089.
82. Braun RP, Baran R, Saurat JH, Thomas L. Surgical Pearl: Dermoscopy of the free edge of the nail to determine the level of nail plate pigmentation and the location of its probable origin in the proximal or distal nail matrix. J Am Acad Dermatol. 2006 Sep;55(3):512-3. doi: 10.1016/j.jaad.2005.09.032
83. Jellinek N. Nail matrix biopsy of longitudinal melanonychia: diagnostic algorithm including the matrix shave biopsy. J Am Acad Dermatol. 2007 May;56(5):803-10. doi: 10.1016/j.jaad.2006.12.001
84. Starace M, Alessandrini A, Brandi N, Piraccini BM. Use of Nail Dermoscopy in the Management of Melanonychia: Review. Dermatol Pract Concept. 2019 ;9(1):38-43. doi: 10.5826/dpc.0901a10
85. Tosti A, Piraccini BM, de Farias DC. Dealing with melanonychia. Semin Cutan Med Surg. 2009;28(1):49–54.
86. Hirata SH, Yamada S, Enokihara MY, et al. Patterns of nail matrix and bed of longitudinal melanonychia by intraoperative der matoscopy. J Am Acad Dermatol. 2011;65(2):297–303.
87. Xavier-Júnior JC, Munhoz T, Souza V, de Campos EB, Stolf HO, Marques ME. Focal invasiveness in complete histological analyses of a large acral lentiginous melanoma. Diagn Pathol. 2015 Jun 20;10:73. doi: 10.1186/s13000-015-0307-z
88. Montenegro Jaramillo SE, Jo G, Darmawan CC, Lee C, Mun JH. Dermoscopic findings of Spitz nevus on acral volar skin. Indian J Dermatol Venereol Leprol. 2019 Nov-Dec;85(6):629-632. doi: 10.4103/ijdvl.IJDVL_728_18
89. Wiedemeyer K, Guadagno A, Davey J, Brenn T. Acral spitz nevi: A clinicopathologic study of 50 cases with immunohistochemical analysis of P16 and P21 expression. Am J Surg Pathol 2018;42:821-7.
90. Yamaura M, Takata M, Miyazaki A, Saida T. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ. Arch. Dermatol. 2005;141:1413–1418. doi: 10.1001/arch derm.141.11.1413
91. Zeng W, Zhang W, Feng J, He X, Lu H. Expression of OPN3 in acral lentiginous melanoma and its associated with clinico histopathologic features and prognosis. Immun Inflamm Dis. 2021 Sep;9(3):840-850. doi: 10.1002/iid3.438
92. Puglisi R, Bellenghi M, Pontecorvi G, Pallante G, Carè A, Mattia G. Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma. Cancers (Basel). 2021 Jun 9;13(12):2875. doi: 10.3390/cancers13122875
1. Kolm I, Hofbauer G, Braun RP. Hautkrebsvorsorge [Early diagnosis of skin cancer]. Ther Umsch. 2010;67(9):439-46. German. doi: 10.1024/0040-5930/a000077
2. Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma. Mod Pathol. 2021 Mar;34(3):572-583. doi: 10.1038/s41379-020-0641-x
3. Basurto-Lozada P, Molina-Aguilar C, Castaneda-Garcia C, et al. Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease. Pigment Cell Melanoma Res. 2021;34(1):59-71. doi:10.1111/pcmr.12885
4. Hogue L., Harvey V.M. Basal Cell Carcinoma, Squamous Cell Carcinoma, and Cutaneous Melanoma in Skin of Color Patients. Dermatol.Clin. 2019;37(4):519-526.
5. Ozdemir F, Errico MA, Yaman B, Karaarslan I. Acral lentiginous melanoma in the Turkish population and a new dermoscopic clue for the diagnosis. Dermatol Pract Concept. 2018;8(2):140-148. doi:10.5826/dpc.0802a14
6. Elefanti L, Zamuner C, Del Fiore P, Stagni C, Pellegrini S, Dall'Olmo L, Fabozzi A, Senetta R, Ribero S, Salmaso R, Mocellin S, Bassetto F, Cavallin F, Tosi AL, Galuppini F, Dei Tos AP, Menin C, Cappellesso R. The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI). Int J Mol Sci. 2021 Apr 7;22(8):3826. doi:10.3390/ijms22083826
7. Goydos JS, Shoen SL. Acral Lentiginous Melanoma. Cancer Treat Res. 2016;167:321-9. doi: 10.1007/978-3-319-22539-5_14
8. Saida T, Miyazaki A, Oguchi S, Ishihara Y, Yamazaki Y, Murase S, et al. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan. Arch Dermatol 2004; 140: 1233-1238. doi: 10.1001 / archderm.140.10.1233Fortin P.T.,
9. Freiberg A.A., Rees R., Sondak V.K., Johnson T.M. Malignant melanoma of the foot and ankle. J. Bone Jt. Surg. 1995;77:1396–1403. doi: 10.2106/00004623-199509000-00016
10. Howard MD, Xie C, Wee E, Wolfe R, McLean CA, Kelly JW, Pan Y. Acral lentiginous melanoma: differences in survival compared with other subtypes. Br J Dermatol. 2020 Apr;182(4):1056-1057. doi: 10.1111/bjd.18620.
11. Saida T, Koga H, Uhara H. Key points in dermoscopic differentiation between early acral melanoma and acral nevus. J Dermatol. 2011;38(1):25-34. doi: 10.1111/j.1346-8138.2010.01174.x.
12. Byrd KMWilson DCHoyler SSPeck GL Advanced presentation of melanoma in African Americans. J Am Acad Dermatol 2004;50 (1) 21- 24
13. Phan A, Dalle S, Touzet S, Ronger-Savlé S, Balme B, Thomas L. Dermoscopic features of acral lentiginous melanoma in a large series of 110 cases in a white population. Br J Dermatol. 2010 Apr;162(4):765-71. doi: 10.1111/j.1365-2133.2009.09594.x. Epub 2009 Nov 18. PMID: 19922528.
14. Desai A, Ugorji R, Khachemoune A. Acral melanoma foot lesions. Part 1: epidemiology, aetiology, and molecular pathology. Clin Exp Dermatol. 2017 Dec;42(8):845-848. doi: 10.1111/ced.13243
15. Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145(4):427-434. doi:10.1001/archdermatol.2008.609
16. Arrington JH, Reed RJ, Ichinose H, Krementz ET. Plantar lentiginous melanoma: A distinctive variant of human cutaneous malignant melanoma. Am Journal of Surgical Pathology. 1977;1(2):131–143.
17. Durbec F., Martin L., Derancourt C., Grange F. Melanoma of the hand and foot: Epidemiological, prognostic and genetic features. A systematic review. Br. J. Dermatol. 2012;166:727–739. doi: 10.1111/j.1365-2133.2011.10772.x 9-12
18. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET; Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007 Mar;82(3):364-80. doi: 10.4065/82.3.364
19. Cabrera, M., Silva, V., Díaz de Medina, DJ, Hoell, B., Guglielmetti, V., Rohmann, K. et al. (1994). Estudio clinico de 113 casos demelanoma maligno . Revista Medica de Chile , 122 ( 8 ), 900–906.
20. Feibleman CE, Stoll H, Maize JC. Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer. 1980 Dec1;46(11):2492-504. doi:10.1002/1097-0142(19801201)46:11<2492::aid cncr2820461130>3.0.co;2-j
21. Minagawa A, Omodaka T, Okuyama R. Melanomas and Mechanical Stress Points on the Plantar Surface of the Foot. N Engl J Med. 2016 Jun 16;374(24):2404-6
22. Sheen, Y.‐S. , Liao, Y.‐H. , Lin, M.‐H. , Chen, J.‐S. , Liau, J.‐Y. , Tseng, Y.‐J., et al. A clinicopathological analysis of 153 acralmelanomas and the relevance of mechanical stress. Scientific Reports, 2017; 7(1), 5564.
23. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41:45–60
24. Usher-Smith JA, Emery J, Kassianos AP, Walter FM. Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014;23:1450–63.
25. Gruber SB, Armstrong BK. Cutaneous and ocular melanoma. In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2006. pp. 1196–1229.
26. Garibyan L,Fisher DE.How sunlight causes melanoma.Curr Oncol Rep.2010 Sep;12(5):319-26. doi: 10.1007/s11912-010-0119-y.
27. Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. Arch Pathol Lab Med. 2020 Apr;144(4):500-522. doi: 10.5858/arpa.2019-0561-RA.
28. Fallah, M. , Pukkala, E. , Sundquist, K. , Tretli, S. , Olsen, J. H. , Tryggvadottir, L. , & Hemminki, K. (2014). Familial melanoma by histology and age: Joint data from five Nordic countries. European Journal of Cancer, 2014; 50(6), 1176–1183.10.1016/j.ejca.2013.12.023
29. Liu XK, Li J. Acral lentiginous melanoma. Lancet.2018 Jun 9;391(10137):e21. doi: 10.1016/S0140-6736(18)31071-7.]. Bello DM,Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013 Oct;20(11):3618-25. doi: 10.1245/s10434-013-3089-0
30. Bradford P.T. Skin Cancer in Skin of Color. Dermatol Nurs. 2009:21(4): 170–178].
31. Ward-Peterson M, Acuna JM, Alkhalifah MK, Nasiri AM, Al-Akeel ES, Alkhaldi TM, et al. Association between race/ethnicity and survival of melanoma patients in the United States over 3 decades: A secondary analysis of SEER data. Medicine. 2016;95(17):e3315.
32. Culp MB, Lunsford NB. Melanoma Among Non-Hispanic Black Americans. Prev Chronic Dis 2019;16:180640.
33. Oh TS, Bae EJ, Ro KW, Seo SH, Son SW, Kim IH. Acral Lentiginous Melanoma Developing during Long-standing Atypical Melanosis: Usefulness of Dermoscopy for Detection of Early Acral Melanoma. Ann Dermatol. 2011;23(3):400-404. doi:10.5021/ad.2011.23.3.400
34. Park HS, Cho KH. Acral lentiginous melanoma in situ: a diagnostic and management challenge. Cancers (Basel). 2010;2(2):642-652. doi:10.3390/cancers2020642.
35. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902-8. doi: 10.1097/00000658-197011000-00017.12885
36. Seyed Jafari SM, Lieberherr S, Cazzaniga S, Beltraminelli H, Haneke E, Hunger RE. Melanoma of the Nail Apparatus: An Analysis of Patients' Survival and Associated Factors. Dermatology. 2022;238(1):156-160. doi: 10.1159/000514493.
37. Liopyris K., Navarrete-Dechent C., Mancebo S.E. et al. Dermoscopic appearance of amelanotic volar melanoma compared with volar angioma. JAMA Dermatol. 2019;155(4):500-501. doi:10.1001/jamadermatol.2018.5487
38. Chang JW. Acral Melanoma: A Unique Disease in Asia. JAMA Dermatol. 2013;149(11):1272–1273. doi:10.1001/jamadermatol.2013.5941
39. Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013 Oct;20(11):3618-25. doi: 10.1245/s10434-013-3089-0.
40. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008 Jan 1;26(1):66-75. doi:10.1200/JCO.2007.12.3604.
41. Hall KH, Rapini RP. Acral Lentiginous Melanoma. 2021 Jul 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32644539.
42. Rigby HS, Briggs JC. Subungual melanoma: a clinico-pathological study of 24 cases. Br J Plast Surg. 1992 May-Jun;45(4):275-8. doi: 10.1016/0007-1226(92)90051-x
43. Mikhail GR. Hutchinson's sign. J Dermatol Surg Oncol. 1986 May;12(5):519-21. doi: 10.1111/j.1524 4725.1986.tb01943.x
44. DeMartinis NC, Cohen PR. Non-Melanoma-Associated Dyschromia of the Proximal Nail Fold. Cureus. 2016;9;8(12):e922. doi:10.7759/cureus.922.
45. Kawabata Y, Ohara K, Hino H, Tamaki K. Two kinds of Hutchinson's sign, benign and malignant. J Am Acad Dermatol. 2001 Feb;44(2):305-7. doi: 10.1067/mjd.2001.112398
46. Dika E, Patrizi A, Fanti PA, Chessa MA, Reggiani C, Barisani A, Piraccini BM. The Prognosis of Nail Apparatus Melanoma: 20 Years of Experience from a Single Institute. Dermatology. 2016;232(2):177-84. doi: 10.1159/000441293
47. Blessing K., Kernohan N.M., Park K.G.M. Subungual malignant melanoma: Clinicopathological features of 100 cases. Histopathology. 1991;19:425–430. doi: 10.1111/j.1365-2559.1991.tb00232.x.
48. Geizhals S, Lipner SR. Retrospective Case Series on Risk Factors, Diagnosis and Treatment of Pseudomonas aeruginosa Nail In fections. Am J Clin Dermatol. 2020 Apr;21(2):297-302. doi: 10.1007/s40257-019-00476-0.
49. Lee H, Mun JH, Cho S, Park H. Clinical analysis of Pseudomonas aeruginosa-positive and -negative green nail syndrome cases:A single center retrospective analysis. J Dermatol. 2021 Jul;48(7):1073-1076. doi: 10.1111/1346-8138.15832.
50. Glaser DA, Remlinger K. Blue nails and acquired immunodeficiency syndrome: not always associated with azidothymidine use.Cutis. 1996 ;57(4):243-4.
51. Vignes S, Baran R. Yellow nail syndrome:a review. Orphanet J Rare Dis. 2017 Feb 27;12(1):42. doi:10.1186/s13023-017-0594-4.
52. Tokonami A, Ohta R, Tanaka Y, Amano S, Sano C. Pericarditis With Cardiac Tamponade Mimicking Yellow Nail Syndrome in a Patient With Rheumatoid Arthritis and a Paucity of Joint Symptoms. Cureus. 2022 Jan 23;14(1):e21523. doi: 10.7759/cureus.21523.
53. Fukaya T, Kasai H, Saito M, Sasatani Y, Urushibara T, Sakao S. Yellow nail syndrome with massive chylothorax after esophagectomy: A case report. Respir Med Case Rep. 2021 Jun 12;33:101448. doi: 10.1016/j.rmcr.2021.101448.
54. Akcam M, Artan R, Akcam FZ, Yilmaz A. Nail discoloration induced by doxycycline. Pediatr Infect Dis J. 2005 Sep;24(9):845-6. doi: 10.1097/01.inf.0000177283.71692.56
55. Oppel T, Korting HC. Onychodystrophy and its management. Ger Med Sci. 2003;1:Doc02.
56. Kaur R, Kashyap B, Bhalla P. Onychomycosis--epidemiology, diagnosis and management. Indian J Med Microbiol. 2008 Apr-Jun;26(2):108-16
57. Jefferson J, Rich P. Melanonychia. Dermatol Res Pract. 2012;2012:952186. doi: 10.1155/2012/952186.
58. Skowron F, Combemale P, Faisant M, Baran R, Kanitakis J, Dupin M. Functional melanonychia due to involvement of the nail matrix in systemic lupus erythematosus. J Am Acad Dermatol. 2002 Aug;47(2 Suppl):S187-8. doi: 10.1067/mjd.2002.108494.
59. Koch K, Tikly M. Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus. Lupus. 2019 Jul;28(8):1021-1026. doi: 10.1177/0961203319856091
60. Singal A, Bisherwal K. Melanonychia: Etiology, Diagnosis, and Treatment. Indian Dermatol Online J. 2020;11(1):1-11. Published 2020 Jan 13. doi:10.4103/idoj.IDOJ_167_19
61. Richert B, Iorizzo M, Tosti A, André J. Nail bed lichen planus associated with onychopapilloma. 2007; 156(5) 5:1071-1072.
62. Kumar S, Dixit R, Karmakar S, Paul S. Unusual nail pigmentation following cyclophosphamide-containing chemotherapy regimen. Indian J Pharmacol. 2010 Aug;42(4):243-4. doi: 10.4103/0253-7613.68433
63. Daniel CR, Scher RK. Nail changes caused by systemic drugs or ingestants. Dermatol Clin. 1985 Jul;3(3):491-500.
64. André J, Lateur N. Pigmented nail disorders. Dermatol Clin. 2006;24(3):329-39.
65. Baran R, Kechijian P. Longitudinal melanonychia (melanonychia striata): diagnosis and management. J Am Acad Dermatol. 1989 Dec;21(6):1165-75. doi: 10.1016/s0190-9622(89)70324-8
66. Fernandez‐Flores, A. , & Cassarino, D. S. Histopathological diagnosis of acral lentiginous melanoma in early stages. Annals of Diagnostic Pathology, 2017; 26, 64–69. 10.1016/j.anndiagpath.2016.08.005
67. Goettmann-Bonvallot S, André J, Belaich S. Longitudinal melanonychia in children: a clinical and histopathologic study of 40 cases. J Am Acad Dermatol. 1999 Jul;41(1):17-22. doi: 10.1016/s0190-9622(99)70399-3.
68. Yim SH, Kwon IS, Hong D, Jung KE, Lee Y, Seo YJ, Choi CW. Predictor of Subungual Melanoma against Benign Longitudinal Melanonychia: A Retrospective Cohort Study from Korea. Ann Dermatol. 2021 Apr;33(2):147-153. doi: 10.5021/ad.2021.33.2.147.
69. Ko D, Oromendia C, Scher R, Lipner SR. Retrospective single-center study evaluating clinical and dermoscopic features of lon gitudinal melanonychia, ABCDEF criteria, and risk of malignancy. J Am Acad Dermatol. 2019 May;80(5):1272-1283. doi:10.1016/j.jaad.2018.08.033.
70. Levit EK, Kagen MH, Scher RK, Grossman M, Altman E. The ABC rule for clinical detection of subungual melanoma. J Am AcadDermatol. 2000 Feb;42(2 Pt 1):269-74. doi: 10.1016/S0190-9622(00)90137-3.
71. Sawada M, Yokota K, Matsumoto T, Shibata S, Yasue S, Sakakibara A, Kono M, Akiyama M. Proposed classification of longitudinal melanonychia based on clinical and dermoscopic criteria. Int J Dermatol. 2014 May;53(5):581-5. doi: 10.1111/ijd.12001
72. Ezenwa E, Stein JA, Krueger L. Dermoscopic features of neoplasms in skin of color: A review. Int J Womens Dermatol. 2021;7(2):145-151. Published 2021 Jan 19. doi:10.1016/j.ijwd.2020.11.009
73. Braun RP, Thomas L, Dusza SW, Gaide O, Menzies S, Dalle S, Blum A, Argenziano G, Zalaudek I, Kopf A, Rabinovitz H, Oliviero M, Perrinaud A, Cabo H, Pizzichetta M, Pozo L, Langford D, Tanaka M, Saida T, Perusquia Ortiz AM, Kreusch J, De Giorgi V, Piccolo D, Grichnik JM, Kittler H, Puig S, Malvehy J, Seidenari S, Stanganelli I, French L, Marghoob AA. Dermoscopy of acral melanoma: a multicenter study on behalf of the international dermoscopy society. Dermatology. 2013;227(4):373-80. doi:10.1159/000356178.
74. Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol. 1987;17:571–583. doi: 10.1016/S0190-9622(87)70239-4
75. Kittler H. Evolution of the Clinical, Dermoscopic and Pathologic Diagnosis of Melanoma. Dermatol Pract Concept. 2021 Jul 1;11(Suppl 1):e2021163S. doi: 10.5826/dpc.11S1a163S
76. Lallas, A. , Kyrgidis, A. , Koga, H. , Moscarella, E. , Tschandl, P. , Apalla, Z. , … Argenziano, G. (2015). The BRAAFF checklist: A new dermoscopic algorithm for diagnosing acral melanoma. British Journal of Dermatology, 173(4), 1041–1049.
77. Saida T, Koga H. Dermoscopic patterns of acral melanocytic nevi: their variations, changes, and significance. Arch Dermatol. 2007 Nov;143(11):1423-6. doi: 10.1001/archderm.143.11.1423.
78. Wawrzynkiewicz M, Pastuszczak M, Chlebicki M, Wojas-Pelc A. Acral melanocytic nevi in the Polish population: prevalence, clinical characteristics and dermoscopic patterns. Postepy Dermatol Alergol. 2019 Oct;36(5):581-588. doi: 10.5114/ada.2018.77500.
79. Han B, Hur K, Ohn J, Lim SS, Mun JH. Acral lentiginous melanoma in situ: dermoscopic features and management strategy. SciRep. 2020 Nov 25;10(1):20503. doi: 10.1038/s41598-020-77425-z.
80. Darmawan CC, Jo G, Montenegro SE, Kwak Y, Cheol L, Cho KH, Mun JH. J Am Acad Dermatol. Early detection of acral melanoma: A review of clinical, dermoscopic, histopathologic, and molecular characteristics.2019; 81(3):805-812.
81. Roh D, Shin K, Kim WI, Yang MY, Lee WK, Kim HS, Ko HC, Kim BS, Kim MB. Comparison of dermoscopic features between congenital and acquired acral melanocytic nevi in Korean patients. J Eur Acad Dermatol Venereol. 2020 May;34(5):1004-1009. doi: 10.1111/jdv.16089.
82. Braun RP, Baran R, Saurat JH, Thomas L. Surgical Pearl: Dermoscopy of the free edge of the nail to determine the level of nail plate pigmentation and the location of its probable origin in the proximal or distal nail matrix. J Am Acad Dermatol. 2006 Sep;55(3):512-3. doi: 10.1016/j.jaad.2005.09.032
83. Jellinek N. Nail matrix biopsy of longitudinal melanonychia: diagnostic algorithm including the matrix shave biopsy. J Am Acad Dermatol. 2007 May;56(5):803-10. doi: 10.1016/j.jaad.2006.12.001
84. Starace M, Alessandrini A, Brandi N, Piraccini BM. Use of Nail Dermoscopy in the Management of Melanonychia: Review. Dermatol Pract Concept. 2019 ;9(1):38-43. doi: 10.5826/dpc.0901a10
85. Tosti A, Piraccini BM, de Farias DC. Dealing with melanonychia. Semin Cutan Med Surg. 2009;28(1):49–54.
86. Hirata SH, Yamada S, Enokihara MY, et al. Patterns of nail matrix and bed of longitudinal melanonychia by intraoperative der matoscopy. J Am Acad Dermatol. 2011;65(2):297–303.
87. Xavier-Júnior JC, Munhoz T, Souza V, de Campos EB, Stolf HO, Marques ME. Focal invasiveness in complete histological analyses of a large acral lentiginous melanoma. Diagn Pathol. 2015 Jun 20;10:73. doi: 10.1186/s13000-015-0307-z
88. Montenegro Jaramillo SE, Jo G, Darmawan CC, Lee C, Mun JH. Dermoscopic findings of Spitz nevus on acral volar skin. Indian J Dermatol Venereol Leprol. 2019 Nov-Dec;85(6):629-632. doi: 10.4103/ijdvl.IJDVL_728_18
89. Wiedemeyer K, Guadagno A, Davey J, Brenn T. Acral spitz nevi: A clinicopathologic study of 50 cases with immunohistochemical analysis of P16 and P21 expression. Am J Surg Pathol 2018;42:821-7.
90. Yamaura M, Takata M, Miyazaki A, Saida T. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ. Arch. Dermatol. 2005;141:1413–1418. doi: 10.1001/arch derm.141.11.1413
91. Zeng W, Zhang W, Feng J, He X, Lu H. Expression of OPN3 in acral lentiginous melanoma and its associated with clinico histopathologic features and prognosis. Immun Inflamm Dis. 2021 Sep;9(3):840-850. doi: 10.1002/iid3.438
92. Puglisi R, Bellenghi M, Pontecorvi G, Pallante G, Carè A, Mattia G. Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma. Cancers (Basel). 2021 Jun 9;13(12):2875. doi: 10.3390/cancers13122875
1. Kolm I, Hofbauer G, Braun RP. Hautkrebsvorsorge [Early diagnosis of skin cancer]. Ther Umsch. 2010;67(9):439-46. German. doi: 10.1024/0040-5930/a000077
2. Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma. Mod Pathol. 2021 Mar;34(3):572-583. doi: 10.1038/s41379-020-0641-x
3. Basurto-Lozada P, Molina-Aguilar C, Castaneda-Garcia C, et al. Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease. Pigment Cell Melanoma Res. 2021;34(1):59-71. doi:10.1111/pcmr.12885
4. Hogue L., Harvey V.M. Basal Cell Carcinoma, Squamous Cell Carcinoma, and Cutaneous Melanoma in Skin of Color Patients. Dermatol.Clin. 2019;37(4):519-526.
5. Ozdemir F, Errico MA, Yaman B, Karaarslan I. Acral lentiginous melanoma in the Turkish population and a new dermoscopic clue for the diagnosis. Dermatol Pract Concept. 2018;8(2):140-148. doi:10.5826/dpc.0802a14
6. Elefanti L, Zamuner C, Del Fiore P, Stagni C, Pellegrini S, Dall'Olmo L, Fabozzi A, Senetta R, Ribero S, Salmaso R, Mocellin S, Bassetto F, Cavallin F, Tosi AL, Galuppini F, Dei Tos AP, Menin C, Cappellesso R. The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI). Int J Mol Sci. 2021 Apr 7;22(8):3826. doi:10.3390/ijms22083826
7. Goydos JS, Shoen SL. Acral Lentiginous Melanoma. Cancer Treat Res. 2016;167:321-9. doi: 10.1007/978-3-319-22539-5_14
8. Saida T, Miyazaki A, Oguchi S, Ishihara Y, Yamazaki Y, Murase S, et al. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan. Arch Dermatol 2004; 140: 1233-1238. doi: 10.1001 / archderm.140.10.1233Fortin P.T.,
9. Freiberg A.A., Rees R., Sondak V.K., Johnson T.M. Malignant melanoma of the foot and ankle. J. Bone Jt. Surg. 1995;77:1396–1403. doi: 10.2106/00004623-199509000-00016
10. Howard MD, Xie C, Wee E, Wolfe R, McLean CA, Kelly JW, Pan Y. Acral lentiginous melanoma: differences in survival compared with other subtypes. Br J Dermatol. 2020 Apr;182(4):1056-1057. doi: 10.1111/bjd.18620.
11. Saida T, Koga H, Uhara H. Key points in dermoscopic differentiation between early acral melanoma and acral nevus. J Dermatol. 2011;38(1):25-34. doi: 10.1111/j.1346-8138.2010.01174.x.
12. Byrd KMWilson DCHoyler SSPeck GL Advanced presentation of melanoma in African Americans. J Am Acad Dermatol 2004;50 (1) 21- 24
13. Phan A, Dalle S, Touzet S, Ronger-Savlé S, Balme B, Thomas L. Dermoscopic features of acral lentiginous melanoma in a large series of 110 cases in a white population. Br J Dermatol. 2010 Apr;162(4):765-71. doi: 10.1111/j.1365-2133.2009.09594.x. Epub 2009 Nov 18. PMID: 19922528.
14. Desai A, Ugorji R, Khachemoune A. Acral melanoma foot lesions. Part 1: epidemiology, aetiology, and molecular pathology. Clin Exp Dermatol. 2017 Dec;42(8):845-848. doi: 10.1111/ced.13243
15. Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145(4):427-434. doi:10.1001/archdermatol.2008.609
16. Arrington JH, Reed RJ, Ichinose H, Krementz ET. Plantar lentiginous melanoma: A distinctive variant of human cutaneous malignant melanoma. Am Journal of Surgical Pathology. 1977;1(2):131–143.
17. Durbec F., Martin L., Derancourt C., Grange F. Melanoma of the hand and foot: Epidemiological, prognostic and genetic features. A systematic review. Br. J. Dermatol. 2012;166:727–739. doi: 10.1111/j.1365-2133.2011.10772.x 9-12
18. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET; Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007 Mar;82(3):364-80. doi: 10.4065/82.3.364
19. Cabrera, M., Silva, V., Díaz de Medina, DJ, Hoell, B., Guglielmetti, V., Rohmann, K. et al. (1994). Estudio clinico de 113 casos demelanoma maligno . Revista Medica de Chile , 122 ( 8 ), 900–906.
20. Feibleman CE, Stoll H, Maize JC. Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer. 1980 Dec1;46(11):2492-504. doi:10.1002/1097-0142(19801201)46:11<2492::aid cncr2820461130>3.0.co;2-j
21. Minagawa A, Omodaka T, Okuyama R. Melanomas and Mechanical Stress Points on the Plantar Surface of the Foot. N Engl J Med. 2016 Jun 16;374(24):2404-6
22. Sheen, Y.‐S. , Liao, Y.‐H. , Lin, M.‐H. , Chen, J.‐S. , Liau, J.‐Y. , Tseng, Y.‐J., et al. A clinicopathological analysis of 153 acralmelanomas and the relevance of mechanical stress. Scientific Reports, 2017; 7(1), 5564.
23. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41:45–60
24. Usher-Smith JA, Emery J, Kassianos AP, Walter FM. Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014;23:1450–63.
25. Gruber SB, Armstrong BK. Cutaneous and ocular melanoma. In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2006. pp. 1196–1229.
26. Garibyan L,Fisher DE.How sunlight causes melanoma.Curr Oncol Rep.2010 Sep;12(5):319-26. doi: 10.1007/s11912-010-0119-y.
27. Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. Arch Pathol Lab Med. 2020 Apr;144(4):500-522. doi: 10.5858/arpa.2019-0561-RA.
28. Fallah, M. , Pukkala, E. , Sundquist, K. , Tretli, S. , Olsen, J. H. , Tryggvadottir, L. , & Hemminki, K. (2014). Familial melanoma by histology and age: Joint data from five Nordic countries. European Journal of Cancer, 2014; 50(6), 1176–1183.10.1016/j.ejca.2013.12.023
29. Liu XK, Li J. Acral lentiginous melanoma. Lancet.2018 Jun 9;391(10137):e21. doi: 10.1016/S0140-6736(18)31071-7.]. Bello DM,Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013 Oct;20(11):3618-25. doi: 10.1245/s10434-013-3089-0
30. Bradford P.T. Skin Cancer in Skin of Color. Dermatol Nurs. 2009:21(4): 170–178].
31. Ward-Peterson M, Acuna JM, Alkhalifah MK, Nasiri AM, Al-Akeel ES, Alkhaldi TM, et al. Association between race/ethnicity and survival of melanoma patients in the United States over 3 decades: A secondary analysis of SEER data. Medicine. 2016;95(17):e3315.
32. Culp MB, Lunsford NB. Melanoma Among Non-Hispanic Black Americans. Prev Chronic Dis 2019;16:180640.
33. Oh TS, Bae EJ, Ro KW, Seo SH, Son SW, Kim IH. Acral Lentiginous Melanoma Developing during Long-standing Atypical Melanosis: Usefulness of Dermoscopy for Detection of Early Acral Melanoma. Ann Dermatol. 2011;23(3):400-404. doi:10.5021/ad.2011.23.3.400
34. Park HS, Cho KH. Acral lentiginous melanoma in situ: a diagnostic and management challenge. Cancers (Basel). 2010;2(2):642-652. doi:10.3390/cancers2020642.
35. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902-8. doi: 10.1097/00000658-197011000-00017.12885
36. Seyed Jafari SM, Lieberherr S, Cazzaniga S, Beltraminelli H, Haneke E, Hunger RE. Melanoma of the Nail Apparatus: An Analysis of Patients' Survival and Associated Factors. Dermatology. 2022;238(1):156-160. doi: 10.1159/000514493.
37. Liopyris K., Navarrete-Dechent C., Mancebo S.E. et al. Dermoscopic appearance of amelanotic volar melanoma compared with volar angioma. JAMA Dermatol. 2019;155(4):500-501. doi:10.1001/jamadermatol.2018.5487
38. Chang JW. Acral Melanoma: A Unique Disease in Asia. JAMA Dermatol. 2013;149(11):1272–1273. doi:10.1001/jamadermatol.2013.5941
39. Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013 Oct;20(11):3618-25. doi: 10.1245/s10434-013-3089-0.
40. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008 Jan 1;26(1):66-75. doi:10.1200/JCO.2007.12.3604.
41. Hall KH, Rapini RP. Acral Lentiginous Melanoma. 2021 Jul 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32644539.
42. Rigby HS, Briggs JC. Subungual melanoma: a clinico-pathological study of 24 cases. Br J Plast Surg. 1992 May-Jun;45(4):275-8. doi: 10.1016/0007-1226(92)90051-x
43. Mikhail GR. Hutchinson's sign. J Dermatol Surg Oncol. 1986 May;12(5):519-21. doi: 10.1111/j.1524 4725.1986.tb01943.x
44. DeMartinis NC, Cohen PR. Non-Melanoma-Associated Dyschromia of the Proximal Nail Fold. Cureus. 2016;9;8(12):e922. doi:10.7759/cureus.922.
45. Kawabata Y, Ohara K, Hino H, Tamaki K. Two kinds of Hutchinson's sign, benign and malignant. J Am Acad Dermatol. 2001 Feb;44(2):305-7. doi: 10.1067/mjd.2001.112398
46. Dika E, Patrizi A, Fanti PA, Chessa MA, Reggiani C, Barisani A, Piraccini BM. The Prognosis of Nail Apparatus Melanoma: 20 Years of Experience from a Single Institute. Dermatology. 2016;232(2):177-84. doi: 10.1159/000441293
47. Blessing K., Kernohan N.M., Park K.G.M. Subungual malignant melanoma: Clinicopathological features of 100 cases. Histopathology. 1991;19:425–430. doi: 10.1111/j.1365-2559.1991.tb00232.x.
48. Geizhals S, Lipner SR. Retrospective Case Series on Risk Factors, Diagnosis and Treatment of Pseudomonas aeruginosa Nail In fections. Am J Clin Dermatol. 2020 Apr;21(2):297-302. doi: 10.1007/s40257-019-00476-0.
49. Lee H, Mun JH, Cho S, Park H. Clinical analysis of Pseudomonas aeruginosa-positive and -negative green nail syndrome cases:A single center retrospective analysis. J Dermatol. 2021 Jul;48(7):1073-1076. doi: 10.1111/1346-8138.15832.
50. Glaser DA, Remlinger K. Blue nails and acquired immunodeficiency syndrome: not always associated with azidothymidine use.Cutis. 1996 ;57(4):243-4.
51. Vignes S, Baran R. Yellow nail syndrome:a review. Orphanet J Rare Dis. 2017 Feb 27;12(1):42. doi:10.1186/s13023-017-0594-4.
52. Tokonami A, Ohta R, Tanaka Y, Amano S, Sano C. Pericarditis With Cardiac Tamponade Mimicking Yellow Nail Syndrome in a Patient With Rheumatoid Arthritis and a Paucity of Joint Symptoms. Cureus. 2022 Jan 23;14(1):e21523. doi: 10.7759/cureus.21523.
53. Fukaya T, Kasai H, Saito M, Sasatani Y, Urushibara T, Sakao S. Yellow nail syndrome with massive chylothorax after esophagectomy: A case report. Respir Med Case Rep. 2021 Jun 12;33:101448. doi: 10.1016/j.rmcr.2021.101448.
54. Akcam M, Artan R, Akcam FZ, Yilmaz A. Nail discoloration induced by doxycycline. Pediatr Infect Dis J. 2005 Sep;24(9):845-6. doi: 10.1097/01.inf.0000177283.71692.56
55. Oppel T, Korting HC. Onychodystrophy and its management. Ger Med Sci. 2003;1:Doc02.
56. Kaur R, Kashyap B, Bhalla P. Onychomycosis--epidemiology, diagnosis and management. Indian J Med Microbiol. 2008 Apr-Jun;26(2):108-16
57. Jefferson J, Rich P. Melanonychia. Dermatol Res Pract. 2012;2012:952186. doi: 10.1155/2012/952186.
58. Skowron F, Combemale P, Faisant M, Baran R, Kanitakis J, Dupin M. Functional melanonychia due to involvement of the nail matrix in systemic lupus erythematosus. J Am Acad Dermatol. 2002 Aug;47(2 Suppl):S187-8. doi: 10.1067/mjd.2002.108494.
59. Koch K, Tikly M. Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus. Lupus. 2019 Jul;28(8):1021-1026. doi: 10.1177/0961203319856091
60. Singal A, Bisherwal K. Melanonychia: Etiology, Diagnosis, and Treatment. Indian Dermatol Online J. 2020;11(1):1-11. Published 2020 Jan 13. doi:10.4103/idoj.IDOJ_167_19
61. Richert B, Iorizzo M, Tosti A, André J. Nail bed lichen planus associated with onychopapilloma. 2007; 156(5) 5:1071-1072.
62. Kumar S, Dixit R, Karmakar S, Paul S. Unusual nail pigmentation following cyclophosphamide-containing chemotherapy regimen. Indian J Pharmacol. 2010 Aug;42(4):243-4. doi: 10.4103/0253-7613.68433
63. Daniel CR, Scher RK. Nail changes caused by systemic drugs or ingestants. Dermatol Clin. 1985 Jul;3(3):491-500.
64. André J, Lateur N. Pigmented nail disorders. Dermatol Clin. 2006;24(3):329-39.
65. Baran R, Kechijian P. Longitudinal melanonychia (melanonychia striata): diagnosis and management. J Am Acad Dermatol. 1989 Dec;21(6):1165-75. doi: 10.1016/s0190-9622(89)70324-8
66. Fernandez‐Flores, A. , & Cassarino, D. S. Histopathological diagnosis of acral lentiginous melanoma in early stages. Annals of Diagnostic Pathology, 2017; 26, 64–69. 10.1016/j.anndiagpath.2016.08.005
67. Goettmann-Bonvallot S, André J, Belaich S. Longitudinal melanonychia in children: a clinical and histopathologic study of 40 cases. J Am Acad Dermatol. 1999 Jul;41(1):17-22. doi: 10.1016/s0190-9622(99)70399-3.
68. Yim SH, Kwon IS, Hong D, Jung KE, Lee Y, Seo YJ, Choi CW. Predictor of Subungual Melanoma against Benign Longitudinal Melanonychia: A Retrospective Cohort Study from Korea. Ann Dermatol. 2021 Apr;33(2):147-153. doi: 10.5021/ad.2021.33.2.147.
69. Ko D, Oromendia C, Scher R, Lipner SR. Retrospective single-center study evaluating clinical and dermoscopic features of lon gitudinal melanonychia, ABCDEF criteria, and risk of malignancy. J Am Acad Dermatol. 2019 May;80(5):1272-1283. doi:10.1016/j.jaad.2018.08.033.
70. Levit EK, Kagen MH, Scher RK, Grossman M, Altman E. The ABC rule for clinical detection of subungual melanoma. J Am AcadDermatol. 2000 Feb;42(2 Pt 1):269-74. doi: 10.1016/S0190-9622(00)90137-3.
71. Sawada M, Yokota K, Matsumoto T, Shibata S, Yasue S, Sakakibara A, Kono M, Akiyama M. Proposed classification of longitudinal melanonychia based on clinical and dermoscopic criteria. Int J Dermatol. 2014 May;53(5):581-5. doi: 10.1111/ijd.12001
72. Ezenwa E, Stein JA, Krueger L. Dermoscopic features of neoplasms in skin of color: A review. Int J Womens Dermatol. 2021;7(2):145-151. Published 2021 Jan 19. doi:10.1016/j.ijwd.2020.11.009
73. Braun RP, Thomas L, Dusza SW, Gaide O, Menzies S, Dalle S, Blum A, Argenziano G, Zalaudek I, Kopf A, Rabinovitz H, Oliviero M, Perrinaud A, Cabo H, Pizzichetta M, Pozo L, Langford D, Tanaka M, Saida T, Perusquia Ortiz AM, Kreusch J, De Giorgi V, Piccolo D, Grichnik JM, Kittler H, Puig S, Malvehy J, Seidenari S, Stanganelli I, French L, Marghoob AA. Dermoscopy of acral melanoma: a multicenter study on behalf of the international dermoscopy society. Dermatology. 2013;227(4):373-80. doi:10.1159/000356178.
74. Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol. 1987;17:571–583. doi: 10.1016/S0190-9622(87)70239-4
75. Kittler H. Evolution of the Clinical, Dermoscopic and Pathologic Diagnosis of Melanoma. Dermatol Pract Concept. 2021 Jul 1;11(Suppl 1):e2021163S. doi: 10.5826/dpc.11S1a163S
76. Lallas, A. , Kyrgidis, A. , Koga, H. , Moscarella, E. , Tschandl, P. , Apalla, Z. , … Argenziano, G. (2015). The BRAAFF checklist: A new dermoscopic algorithm for diagnosing acral melanoma. British Journal of Dermatology, 173(4), 1041–1049.
77. Saida T, Koga H. Dermoscopic patterns of acral melanocytic nevi: their variations, changes, and significance. Arch Dermatol. 2007 Nov;143(11):1423-6. doi: 10.1001/archderm.143.11.1423.
78. Wawrzynkiewicz M, Pastuszczak M, Chlebicki M, Wojas-Pelc A. Acral melanocytic nevi in the Polish population: prevalence, clinical characteristics and dermoscopic patterns. Postepy Dermatol Alergol. 2019 Oct;36(5):581-588. doi: 10.5114/ada.2018.77500.
79. Han B, Hur K, Ohn J, Lim SS, Mun JH. Acral lentiginous melanoma in situ: dermoscopic features and management strategy. SciRep. 2020 Nov 25;10(1):20503. doi: 10.1038/s41598-020-77425-z.
80. Darmawan CC, Jo G, Montenegro SE, Kwak Y, Cheol L, Cho KH, Mun JH. J Am Acad Dermatol. Early detection of acral melanoma: A review of clinical, dermoscopic, histopathologic, and molecular characteristics.2019; 81(3):805-812.
81. Roh D, Shin K, Kim WI, Yang MY, Lee WK, Kim HS, Ko HC, Kim BS, Kim MB. Comparison of dermoscopic features between congenital and acquired acral melanocytic nevi in Korean patients. J Eur Acad Dermatol Venereol. 2020 May;34(5):1004-1009. doi: 10.1111/jdv.16089.
82. Braun RP, Baran R, Saurat JH, Thomas L. Surgical Pearl: Dermoscopy of the free edge of the nail to determine the level of nail plate pigmentation and the location of its probable origin in the proximal or distal nail matrix. J Am Acad Dermatol. 2006 Sep;55(3):512-3. doi: 10.1016/j.jaad.2005.09.032
83. Jellinek N. Nail matrix biopsy of longitudinal melanonychia: diagnostic algorithm including the matrix shave biopsy. J Am Acad Dermatol. 2007 May;56(5):803-10. doi: 10.1016/j.jaad.2006.12.001
84. Starace M, Alessandrini A, Brandi N, Piraccini BM. Use of Nail Dermoscopy in the Management of Melanonychia: Review. Dermatol Pract Concept. 2019 ;9(1):38-43. doi: 10.5826/dpc.0901a10
85. Tosti A, Piraccini BM, de Farias DC. Dealing with melanonychia. Semin Cutan Med Surg. 2009;28(1):49–54.
86. Hirata SH, Yamada S, Enokihara MY, et al. Patterns of nail matrix and bed of longitudinal melanonychia by intraoperative der matoscopy. J Am Acad Dermatol. 2011;65(2):297–303.
87. Xavier-Júnior JC, Munhoz T, Souza V, de Campos EB, Stolf HO, Marques ME. Focal invasiveness in complete histological analyses of a large acral lentiginous melanoma. Diagn Pathol. 2015 Jun 20;10:73. doi: 10.1186/s13000-015-0307-z
88. Montenegro Jaramillo SE, Jo G, Darmawan CC, Lee C, Mun JH. Dermoscopic findings of Spitz nevus on acral volar skin. Indian J Dermatol Venereol Leprol. 2019 Nov-Dec;85(6):629-632. doi: 10.4103/ijdvl.IJDVL_728_18
89. Wiedemeyer K, Guadagno A, Davey J, Brenn T. Acral spitz nevi: A clinicopathologic study of 50 cases with immunohistochemical analysis of P16 and P21 expression. Am J Surg Pathol 2018;42:821-7.
90. Yamaura M, Takata M, Miyazaki A, Saida T. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ. Arch. Dermatol. 2005;141:1413–1418. doi: 10.1001/arch derm.141.11.1413
91. Zeng W, Zhang W, Feng J, He X, Lu H. Expression of OPN3 in acral lentiginous melanoma and its associated with clinico histopathologic features and prognosis. Immun Inflamm Dis. 2021 Sep;9(3):840-850. doi: 10.1002/iid3.438
92. Puglisi R, Bellenghi M, Pontecorvi G, Pallante G, Carè A, Mattia G. Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma. Cancers (Basel). 2021 Jun 9;13(12):2875. doi: 10.3390/cancers13122875
